EpiPen Direct Buyers, Mylan Get Final OK On Antitrust Deal
By Jared Foretek · May 22, 2025, 6:53 PM EDT
Mylan Pharmaceuticals' $73.5 million settlement with a class of direct EpiPen buyers has received final approval from a Kansas federal judge, closing out claims from institutional drug resellers that Mylan worked...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login